Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine versus remimazolam during intraoperative nerve monitoring in thyroid surgery
ChiCTR2500098860Phase 4Recruiting
- Sponsor
- Ningbo Medical Centre Lihuili Hospital
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of lidocaine and remimazolam in thyroid disease (2 arms), sponsored by Ningbo Medical Centre Lihuili Hospital. Primary endpoints: Waveform morphology scores of recurrent laryngeal nerve monitoring and Laryngeal reflex. Started Mar 2025; status: recruiting.
02
Drugs
lidocaineremimazolam
03
Conditions
thyroid disease
Beyond the preview
Go deeper on ChiCTR2500098860.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500098860.